Our company number of employees are 420 people, of which CDMO team employees nearly 150 people. Providing product customized services for global customers, our projects are mainly focused on the custom synthesis of sulfur-containing and fluorine-containing chemical fragments and the replacement of imported monopoly chemical products in the field of substitution. The customized fragments for pharmaceutical products cover the diseases of anti-tumor, anti-pneumonia, anti-pulmonary fibrosis and R&D for new drug fragments in the preclinical stage.